4-methylpyridopyrimidinone compounds
US7696213B2 · kind B2 · utility
15Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 13, 2007 |
| Grant date | Apr 13, 2010 |
| Priority date | — |
| Expiry date | Jun 8, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel 4-methylpyridopyrimidinone compounds of Formula (I),and to salts thereof, their synthesis, and their use as inhibitors of phosphoinositide 3-kinase alpha (PI3-Kα).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.